Market Forecast by End User (contract packaging, pharmaceutical manufacturing, retail pharmacy, contract packaging, institutional pharmacy and others), by Product Type (Primary Pharmaceutical Packaging, Secondary Pharmaceutical Packaging and Tertiary Pharmaceutical Packaging), by Material Type (paper & board, Plastic & Polymer, Aluminium Foil, glass and others), By Countries (United Kingdom, France, Germany, Italy and rest of Europe) and Competitive Landscape
Product Code: ETC054752 | Publication Date: Apr 2021 | Updated Date: Dec 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 | |
Report Name | Europe Pharmaceutical Packaging Market |
Forecast Period | 2024-2030 |
Market Size | USD 28.5 billion by 2031 |
CAGR | 6.2% |
Growing Sector | Pharmaceutical manufacturing |
Europe Pharmaceutical Packaging Market report thoroughly covers the market by end user, by product type, by material type and key countries. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Europe Pharmaceutical Packaging Market Size is projected to reach USD 28.5 billion by 2031, growing at a CAGR of 6.2% during the forecast period from 2025 to 2031. As of recent data, the market holds a dominant position globally, driven by increasing pharmaceutical exports and a high prevalence of chronic diseases necessitating diverse drug formulations. Key markets such as Germany and the United Kingdom are leading contributors, owing to their strong pharmaceutical manufacturing bases. The rapid advancements in packaging technologies and sustainable material development also bolster the Europe Pharmaceutical Packaging Market Growth, making it a critical component of the region's healthcare infrastructure.
Europe Pharmaceutical Packaging Market is witnessing robust growth due to the increasing demand for advanced, sustainable, and innovative packaging solutions in the pharmaceutical sector. This growth is fueled by stringent regulatory requirements, advancements in drug delivery technologies, and the expanding pharmaceutical industry across major countries such as the United Kingdom, France, Germany, and Italy. As the pharmaceutical sector emphasizes safety, efficacy, and environmental sustainability, the demand for high-quality packaging materials and systems has surged. Moreover, the adoption of biologics and personalized medicine further elevates the need for specialized and sophisticated packaging solutions, highlighting the strategic importance of this industry in Europe.
According to 6Wresearch, the Europe Pharmaceutical Packaging Market is estimated to grow at a CAGR of 6.2% during the forecast period 2025-2031. The market is fueled by several critical factors, including advancements in drug formulations, an increase in pharmaceutical manufacturing, and the rising demand for innovative and sustainable packaging solutions. The region's expanding geriatric population and the growing prevalence of chronic diseases have driven the need for consistent drug delivery systems, spurring the development of advanced primary and secondary packaging solutions. Additionally, the adoption of biologics and personalized medicines has surged, requiring specialized packaging to maintain drug integrity. Pharmaceutical exports from countries such as Germany and France further bolster the market, while the stringent regulatory landscape ensures a steady demand for compliant packaging solutions. Companies are also investing heavily in eco-friendly materials and smart packaging technologies, such as RFID-enabled systems and tamper-evident features, to meet consumer and regulatory demands.
Despite its growth, the Europe Pharmaceutical Packaging Industry faces notable challenges that could impact its progression. The rising cost of raw materials, particularly biodegradable and sustainable alternatives, poses a significant hurdle for manufacturers striving to align with European Union environmental standards. Moreover, the stringent and diverse regulatory requirements across member states can complicate compliance, leading to increased operational costs and time-intensive approval processes. Counterfeit drugs remain a persistent issue, compelling companies to invest in anti-counterfeit technologies, which can be resource-intensive. Another challenge lies in the rapid advancements in drug formulations, which necessitate constant innovation in packaging solutions, potentially outpacing the capabilities of smaller manufacturers.
Europe Pharmaceutical Packaging Market is witnessing transformative trends that are reshaping the industry landscape. The increasing emphasis on sustainability has driven a shift toward biodegradable, recyclable, and eco-friendly packaging materials, aligning with the European Union’s Green Deal objectives. Technological advancements are also making a significant impact, with the integration of smart packaging features such as temperature monitoring, tamper-evident seals, and RFID tags gaining widespread adoption. These innovations ensure drug safety, enhance supply chain transparency, and improve patient adherence to medication regimens. Furthermore, the growing preference for single-dose and unit-dose packaging reflects the market's response to the demand for convenience and precise drug administration. Automation and digitization in packaging processes, particularly in Germany and the United Kingdom, are enhancing operational efficiency and reducing production costs.
Europe Pharmaceutical Packaging Market presents numerous investment opportunities, driven by the increasing demand for innovative and sustainable packaging solutions. The rising adoption of biologics and biosimilars creates a lucrative market for specialized primary packaging, including prefilled syringes and ampoules. The shift toward eco-friendly materials offers significant potential for investments in research and development of biodegradable polymers and advanced recycling technologies. Moreover, the expansion of the pharmaceutical industry in emerging markets within Europe, supported by government incentives and infrastructural improvements, provides a fertile ground for packaging manufacturers. Collaborative ventures between pharmaceutical companies and packaging solution providers to develop tailored solutions for complex drug formulations further highlight the market's potential for growth and innovation.
Europe Pharmaceutical Packaging Market is characterized by the presence of several leading players, including Gerresheimer AG, Amcor PLC, West Pharmaceutical Services, Inc., and Schott AG. These companies are at the forefront of innovation, focusing on developing sustainable packaging materials, lightweight solutions, and advanced technologies such as RFID-enabled systems and tamper-evident packaging. Gerresheimer AG is particularly renowned for its expertise in glass and plastic primary packaging, catering to the growing demand for biologics and injectable drugs. Amcor PLC has made significant strides in developing recyclable and eco-friendly packaging options, aligning with the region's sustainability goals. West Pharmaceutical Services, Inc., specializes in primary packaging components for injectable medicines, reflecting the rising adoption of biologics. Schott AG is recognized for its innovations in glass packaging, ensuring drug stability and safety.
Governments across Europe are playing a pivotal role in shaping the Europe Pharmaceutical Packaging Industry through targeted initiatives and regulatory measures. The European Union’s emphasis on reducing environmental impact under its Green Deal framework has accelerated the transition to sustainable packaging materials. Investments in healthcare infrastructure and research funding in countries like Germany, France, and Italy are bolstering pharmaceutical manufacturing and, consequently, the demand for advanced packaging solutions. Collaborative efforts to combat counterfeit drugs through regulatory mandates and the promotion of smart packaging technologies are enhancing drug safety across the region. Additionally, initiatives aimed at supporting small and medium-sized enterprises in the pharmaceutical and packaging sectors provide a significant boost to innovation and competitiveness in the Europe Pharmaceutical Packaging Market.
The future of the Europe Pharmaceutical Packaging Market is poised for substantial growth, driven by technological advancements and sustainability initiatives. The integration of smart packaging technologies, such as real-time monitoring systems and blockchain for traceability, is expected to revolutionize the industry, ensuring enhanced drug safety and compliance. Governments are anticipated to implement stricter regulations promoting the use of eco-friendly materials, further shaping the market landscape. The increasing adoption of automation and artificial intelligence in packaging processes will significantly enhance operational efficiency and precision, particularly in high-demand regions like Germany and France. The development of innovative packaging solutions for biologics, vaccines, and other complex drug formulations will remain a key focus area.
The report offers a comprehensive study of the subsequent market segments and their leading categories.
According to Vasu, Senior Research Analyst, 6Wresearch, the pharmaceutical manufacturing segment dominates the market, driven by the increasing demand for drug production and export-oriented activities across Europe. This segment is bolstered by advancements in manufacturing technologies and the adoption of innovative packaging solutions.
Primary pharmaceutical packaging, such as bottles, vials, and blister packs, is the fastest-growing segment. These solutions are critical for maintaining drug efficacy and safety, particularly for biologics and personalized medicines.
Plastic & polymer-based packaging materials are the most widely used, owing to their versatility, durability, and cost-effectiveness. However, the rising focus on sustainability is gradually increasing the adoption of biodegradable polymers.
Germany leads the market due to its strong pharmaceutical manufacturing base and high investment in R&D. The United Kingdom and France also contribute significantly, driven by advancements in healthcare infrastructure and export activities.
The report provides a detailed analysis of the following market segments
1. Executive Summary |
2. Introduction |
2.1. Key Highlights of the Report |
2.2. Report Description |
2.3. Market Scope & Segmentation |
2.4. Research Methodology |
2.5. Assumptions |
3. Europe Pharmaceutical Packaging Market Overview |
3.1. Europe Pharmaceutical Packaging Market Revenues, 2021 & 2031F |
3.2. Europe Pharmaceutical Packaging Market - Industry Life Cycle |
3.3. Europe Pharmaceutical Packaging Market - Porter's Five Forces |
3.4. Europe Pharmaceutical Packaging Market Revenue Share, By End User, 2021 & 2031F |
3.5. Europe Pharmaceutical Packaging Market Revenue Share, By Material Type, 2021 & 2031F |
3.6. Europe Pharmaceutical Packaging Market Revenue Share, By Product Type, 2021 & 2031F |
3.7. Europe Pharmaceutical Packaging Market Revenue Share, By Countries, 2021 & 2031F |
4. Europe Pharmaceutical Packaging Market Dynamics |
4.1. Impact Analysis |
4.2. Market Drivers |
4.3. Market Restraints |
5. Europe Pharmaceutical Packaging Market Trends |
6. Europe Pharmaceutical Packaging Market, By End User |
6.1. Europe Pharmaceutical Packaging Market, By End User |
6.1.1. Overview and Analysis |
6.1.2. Europe Pharmaceutical Packaging Market Revenues, By Pharmaceutical Manufacuturing, 2021 - 2031F |
6.1.3. Europe Pharmaceutical Packaging Market Revenues, By Retail Pharmacy, 2021 - 2031F |
6.1.4. Europe Pharmaceutical Packaging Market Revenues, By Contract Packaging, 2021 - 2031F |
6.1.5. Europe Pharmaceutical Packaging Market Revenues, By Institutional Pharmacy, 2021 - 2031F |
6.1.6. Europe Pharmaceutical Packaging Market Revenues, By Others, 2021 - 2031F |
7. Europe Pharmaceutical Packaging Market, By Material Type |
7.1. Europe Pharmaceutical Packaging Market, By Material Type |
7.1.1. Overview and Analysis |
7.1.2. Europe Pharmaceutical Packaging Market Revenues, By Paper & Board, 2021 - 2031F |
7.1.3. Europe Pharmaceutical Packaging Market Revenues, By Plastic & Polymer, 2021 - 2031F |
7.1.4. Europe Pharmaceutical Packaging Market Revenues, By Metal, 2021 - 2031F |
7.1.5. Europe Pharmaceutical Packaging Market Revenues, By Aluminium Foil, 2021 - 2031F |
7.1.6. Europe Pharmaceutical Packaging Market Revenues, By Others, 2021 - 2031F |
8. Europe Pharmaceutical Packaging Market, By Product Type |
8.1. Europe Pharmaceutical Packaging Market, By Product Type |
8.1.1. Overview and Analysis |
8.1.2. Europe Pharmaceutical Packaging Market Revenues, By Primary Pharmaceutical Packaging, 2021 - 2031F |
8.1.3. Europe Pharmaceutical Packaging Market Revenues, By Secondary Pharmaceutical Packaging Range, 2021 - 2031F |
8.1.4. Europe Pharmaceutical Packaging Market Revenues, By Tertiary Pharmaceutical Packaging, 2021 - 2031F |
10. Italy Pharmaceutical Packaging Market |
10.1. Italy Pharmaceutical Packaging Market, By End User |
10.2. Italy Pharmaceutical Packaging Market, By Material Type |
10.3. Italy Pharmaceutical Packaging Market, By Product Type |
10.4. Italy Pharmaceutical Packaging Market, By Countries |
11. Germany Pharmaceutical Packaging Market |
11.1. Germany Pharmaceutical Packaging Market, By End User |
11.2. Germany Pharmaceutical Packaging Market, By Material Type |
11.3. Germany Pharmaceutical Packaging Market, By Product Type |
11.4. Germany Pharmaceutical Packaging Market, By Countries |
12. United Kingdom Pharmaceutical Packaging Market |
12.1. United Kingdom Pharmaceutical Packaging Market, By End User |
12.2. United Kingdom Pharmaceutical Packaging Market, By Material Type |
12.3. United Kingdom Pharmaceutical Packaging Market, By Product Type |
12.4. United Kingdom Pharmaceutical Packaging Market, By Countries |
13. France Pharmaceutical Packaging Market |
13.1. France Pharmaceutical Packaging Market, By End User |
13.2. France Pharmaceutical Packaging Market, By Material Type |
13.3. France Pharmaceutical Packaging Market, By Product Type |
13.4. France Pharmaceutical Packaging Market, By Countries |
14. Rest of Europe Pharmaceutical Packaging Market |
14.1. Rest of Europe Pharmaceutical Packaging Market Overview |
15. Europe Pharmaceutical Packaging Market Import-Export Trade Statistics |
15.1. Europe Pharmaceutical Packaging Market Export to Major Countries |
15.2. Europe Pharmaceutical Packaging Market Imports from Major Countries |
16. Europe Pharmaceutical Packaging Market Key Performance Indicators |
17. Europe Pharmaceutical Packaging Market - Opportunity Assessment |
17.1. Europe Pharmaceutical Packaging Market Opportunity Assessment, By End User, 2021 & 2031F |
17.2. Europe Pharmaceutical Packaging Market Opportunity Assessment, By Material Type, 2021 & 2031F |
18. Europe Pharmaceutical Packaging Market - Competitive Landscape |
18.1. Europe Pharmaceutical Packaging Market Revenue Share, By Companies, 2024 |
18.2. Europe Pharmaceutical Packaging Market Competitive Benchmarking, By Operating and Technical Parameters |
19. Company Profiles |
20. Recommendations |
21. Disclaimer |